Boutique, Independent Corporate Advisor to the Healthcare Sector

Specialist Capabilities and Deep Experience in Healthcare

Our point of difference is the ability to leverage our wide-ranging experience and deep expertise to provide tailored strategic and financial advisory solutions across all forms of corporate and financing transactions.

Medical Products and Devices

Health Services

Pharma and Life Sciences

Health Technology

Trusted Advice, Innovative Solutions

Our point of difference is the ability to leverage our wide-ranging experience and deep expertise to provide tailored strategic and financial advisory solutions across all forms of corporate and financing transactions.

Mergers and Acquisitions

  • Strategic Reviews
  • Corporate Mergers
  • Takeovers / Schemes of Arrangement
  • Acquisitions
  • Divestitures and Spin-Offs

Capital Raisings

  • Acquisition Financing
  • Project and Corporate Finance
  • Convertibles and Hybrids
  • Initial Public Offerings
  • Rights Issues, Placements and SPPs

Strategic Investments

  • Principal Investments
  • Venture Capital
  • Private Placements
  • Joint Ventures / Strategic Alliances
  • Management Buy-Outs

Our Experience

Our experience includes advising on corporate and financing transactions across the full spectrum of the capital structure and investment lifecycle and with a diverse range of strategic investors, corporates and capital providers. Treadstone or members of its team have led the following transactions in the healthcare industry.

Strategic Investment in Sycle

Strategic Investment in Saluda Medical

Strategic Investment in EarLens Corporation

Value : US$78 million
Date : May 2017
Cochlear acquired audiology software company Sycle
Value : Confidential
Date : September 2016
Cochlear invested in chronic pain management company Saluda Medical
Value : Confidential
Date : June 2016
Cochlear invested in hearing device company Saluda Medical

Our team

Our team draws on our extensive corporate advisory, structuring and transactional experience and global relationships developed across a range of corporates, executives, founders and investors in the healthcare sector over the last 25 years for the maximum benefit of our clients.

Ross King

Ross has extensive experience in all aspects of corporate finance, particularly in mergers and acquisitions and equity funding.
He spent 23 years at Goldman Sachs working in the New York, London, Melbourne and Sydney offices, with a range of senior roles including:

  • 2002 – 2012: Chairman Financing Group, Managing Director and Head of Healthcare, Australia and New Zealand
  • 1996 – 2001: Partner, Executive Director Research Sales – New York
  • 1993 – 1995: Partner, Executive Director Research Sales ­ London
  • 1990 – 1992: Director, Research Division – Melbourne

Over his accomplished career Ross has advised on numerous landmark transactions in the Australian M&A landscape, and his deep experience in investment banking gives him a reputation for sound commercial judgment and absolute integrity with his clients.
Ross is a Director (8 years) of the Medical Research Commercialisation Fund (the largest VC fund in Australia which specialises in the biotech, medtech, and health services sectors funded by numerous superannuation funds, as well as the Federal and State governments of Australia).
Ross completed a Bachelor of Science (Honours) and MBA at the University of Cape Town and received a Graduate Diploma in Engineering from the University of Witwatersrand.
Key healthcare transactions which Ross has advised, arranged or executed include:

  • Cochlear’s creation of their Technology Innovation Fund and venture investments in Saluda Medical and Earlens
  • Cochlear’s acquisition of Entific
  • Ramsay’s acquisition and associated financing (hybrid, AREO, and bridge acquisition financing) of Affinity
  • Healthscope’s acquisition financing of 14 Ramsay hospitals
  • Healthscope’s acquisition financing of Gribbles Pathology Group
  • Healthscope’s acquisition financing of Nova Health

Other roles Ross currently holds include:

  • Board member of the Medical Research Commercialization Fund
  • President of the Foundation Board and member of the Finance Committee of The Kings School
  • Past executive of the Wallaby/Australian Rugby Union Mentoring Program

Sean Hogan

Sean is an experienced senior executive with a broad background in investment banking, merchant banking & investing, capital markets and treasury.
Much of this experience was gained at Goldman Sachs in Australia where he spent 10 years and held a number of senior positions, including:

  • Managing Director, Head of the Principal Investment Area (PIA) in Australia and New Zealand
  • Managing Director, Head of Capital Products Group

PIA managed approximately A$1bn of Goldman Sach’s investable capital. Prior to his time in PIA Sean had extensive experience at Goldman within the Financing Group, co-leading the firm’s efforts in the Capital Products business, which incorporates Goldman Sachs’ Australian debt capital markets, structured financing, leveraged finance and equity linked business. In this capacity Sean lead or was a key advisor on some of Australia’s most prominent financing transactions. During this time he developed a reputation for leadership, innovation, delivery and integrity.

Prior to joining Goldman Sachs in 2002, Sean was Head of Structured Finance and Securitisation at SG Australia and previously held positions with
Westpac Banking Corporation in Treasury and Institutional Banking.

Sean commenced a career in finance with Citibank in 1992, prior to which he was an officer in the Royal Australian Navy. Seancompleted a BA at the University of New South Wales.

Key healthcare transactions which Sean has advised, arranged or executed include:

  • Sale of Vision Senior Living to Metlifecare, NZ
  • Acquisition financing of CVC’s purchase of DCA Group ($2.663bn)
  • Restructure and exit of Goldman Sachs’ Collateral Mezzanine Fund from DCA Group
  • Financing for Ramsay’s acquisition of Affinity ($260m hybrid, $190m AREO and placement, $450m bridge facilities)

Other roles Sean currently holds include:

  • Board member of Standard Media Index (SMI)
  • Chairman of Expert360

Warwick Amos

Warwick joined Treadstone Resource Partners in 2014 and has extensive experience in investment banking, particularly in mergers and acquisitions, equity and debt capital markets, and principal investment transactions.

Prior to joining Treadstone Resource Partners, Warwick worked at Macquarie Capital in the Sydney and Singapore offices and focused primarily on the Telecommunications, Media, Entertainment and Technology sectors.

Warwick has gained experience across a broad range of significant transactions involving a wide range of domestic and international corporate, private equity and institutional clients. Throughout his career, Warwick has advised on significant transactions for leading companies such as Leighton Holdings, Seven Group Holdings, Nine Entertainment Co., Mantra Group and Australia Post.

Warwick holds a Bachelor of Business (Accounting & Finance) from the University of Technology, Sydney and is a member of the Institute of Chartered Accountants

Adam Bill

Adam joined Treadstone Resource Partners in 2016 and has broad experience in investment banking, particularly in mergers and acquisitions, leverage finance and debt and equity capital markets.

Prior to joining Treadstone Resource Partners, Adam worked at Credit Suisse in the Sydney office and Barclays Capital in both the Sydney and London offices focused on Mining & Metals and Oil & Gas.

Prior to joining Barclays in 2010, Adam was a Tax Analyst at Deloitte Touche Tohmatsu in the Private Equity and Mergers and Acquisitions team Adam holds a Bachelor of Commerce and Bachelor of Laws from the University of Queensland and is a qualified Lawyer of the Supreme Court of New South Wales.

Cameron Horsburgh

Cameron joined Treadstone Resource Partners as an Analyst in 2014. Prior to joining, Cameron spent 6 months in the Global Research and Investment Banking Divisions of Standard Chartered Bank, based in London.

While at Standard Chartered, Cameron was involved in a number of significant transactions. Cameron holds a Bachelor of Engineering (Civil) / Bachelor of Economics (Honours)from the University of Queensland. His Honours thesis studied the response of Australian purchasing power to Chinese economic shocks.